Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Helgstrand Terapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   14.2% 18.7% 23.2% 12.7% 12.1% 20.1% 16.1% 15.9%   Credit score (0-100)   16 8 4 17 19 5 11 12   Credit rating   BB B B BB BB B BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 31 40 100 0 0 0 0   Gross profit   -1.3 -0.0 40.3 36.8 195 187 0.0 0.0   EBITDA   -1.3 -12.1 6.3 29.8 -16.0 -53.7 0.0 0.0   EBIT   -1.3 -13.5 4.5 24.6 -16.0 -53.7 0.0 0.0   Pre-tax profit (PTP)   -1.3 -13.6 4.5 24.6 -16.3 -53.9 0.0 0.0   Net earnings   -1.3 -13.6 4.5 24.6 -16.3 -53.9 0.0 0.0   Pre-tax profit without non-rec. items   -1.3 -13.6 4.5 24.6 -16.3 -53.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -1.2 26.5 31.1 60.5 14.4 -39.4 -79.4 -79.4   Interest-bearing liabilities   2.2 0.2 0.0 0.0 0.0 0.0 79.4 79.4   Balance sheet total (assets)   0.9 26.8 30.3 67.4 85.2 6.1 0.0 0.0   Net Debt   1.2 0.1 -5.3 -19.8 -4.1 -6.1 79.4 79.4     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 31 40 100 0 0 0 0   Net sales growth   0.0% 0.0% 30.3% 147.1% -100.0% 0.0% 0.0% 0.0%   Gross profit   -1.3 -0.0 40.3 36.8 195 187 0.0 0.0   Gross profit growth   0.0% 97.7% 0.0% -8.7% 429.6% -4.0% -100.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 -10.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1 27 30 67 85 6 0 0   Balance sheet change%   0.0% 2,716.5% 13.2% 122.6% 26.3% -92.9% -100.0% 0.0%   Added value   -1.3 -12.1 16.3 29.8 -10.8 -53.7 0.0 0.0   Added value %   0.0% -39.0% 40.5% 30.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 -1 -2 -5 0 0 0 0   Net sales trend   0.0 0.0 1.0 2.0 -1.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% -39.0% 15.6% 30.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% -43.7% 11.3% 24.7% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 43,571.0% 11.3% 67.0% -8.2% -28.7% 0.0% 0.0%   Net Earnings %   0.0% -43.9% 11.2% 24.7% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% -39.2% 15.6% 30.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% -43.9% 11.2% 24.7% 0.0% 0.0% 0.0% 0.0%   ROA %   -61.3% -93.3% 15.9% 50.4% -21.0% -82.2% 0.0% 0.0%   ROI %   -61.3% -93.3% 15.7% 53.8% -42.8% -745.5% 0.0% 0.0%   ROE %   -141.6% -98.7% 15.7% 53.8% -43.5% -525.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -56.7% 99.2% 97.6% 89.7% 16.9% -86.7% -100.0% -100.0%   Relative indebtedness %   0.0% 0.7% -1.9% 7.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.2% -15.0% -12.9% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -92.6% -0.5% -84.0% -66.4% 25.7% 11.3% 0.0% 0.0%   Gearing %   -176.3% 0.8% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 4.9% 17.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 120.0 -40.4 9.7 1.2 0.1 0.0 0.0   Current Ratio   0.4 120.0 -40.4 9.7 1.2 0.1 0.0 0.0   Cash and cash equivalent   0.9 0.2 5.3 19.8 4.1 6.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 21.7 7.3 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 6,927.8 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 86.5% 75.2% 67.7% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1.2 26.5 31.1 60.5 14.4 -39.4 -39.7 -39.7   Net working capital %   0.0% 85.8% 77.0% 60.8% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 -11 -54 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 -16 -54 0 0   EBIT / employee   0 0 0 0 -16 -54 0 0   Net earnings / employee   0 0 0 0 -16 -54 0 0